Abstract
Purpose
To report surgical outcomes of a Microhook ab interno trabeculotomy (µLOT) procedure for glaucoma secondary to hereditary transthyretin amyloidosis (ATTRv).
Study design
Retrospective case series.
Methods
Medical records of patients with glaucoma secondary to ATTRv with transthyretin Val30Met variant, who underwent µLOT, were retrospectively reviewed. Surgical success was categorized according to the postoperative intraocular pressures (IOPs, mmHg) as follows: (a) 6 ≤ IOP ≤ 21; (b) 6 ≤ IOP ≤ 18; and (c) 6 ≤ IOP ≤ 15, without light perception loss or additional glaucoma surgery. Secondary outcomes were glaucoma medication scores and postoperative complications.
Results
This study included 18 eyes (13 patients, 6 men). The mean follow-up period was 25.2±9.8 months (7–38 months). Kaplan–Meier analysis indicated success rates of (a) 1.00 at 6, 1.00 at 12, and 0.43 at 24 months; (b), 1.00 at 6, 0.93 at 12, and 0.43 at 24 months; (c) 0.94 at 6, 0.75 at 12, and 0.27 at 24 months after operation. Postoperative IOPs were significantly reduced from the baseline of 25.2±5.8 mmHg to 11.5±2.7 at 3, 12.3±4.1 at 6, and 13.8±3.9 at 12 months (Dunnett's test). Medication scores were also improved at 3 and 6 months but without a significant reduction at 12 months. There were no severe complications requiring surgical intervention except for additional glaucoma surgery.
Conclusion
µLOT for secondary glaucoma in ATTRv is safe and effective 1 year after surgery, but the effects diminish after 2 years.
Similar content being viewed by others
Data availability
The datasets analyzed during the current study are not publicly available because of the hospital’s policy to protect the personal information of the participants but are available from the corresponding author upon reasonable request.
References
Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268:2109–22.
Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57:829–37.
Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol. 1997;81:295–8.
Reynolds MM, Veverka KK, Gertz MA, Dispenzieri A, Zeldenrust SR, Leung N, et al. Ocular manifestations of familial transthyretin amyloidosis. Am J Ophthalmol. 2017;183:156–62.
Kakihara S, Hirano T, Matsuda Y, Takano D, Imai A, Miyahara T, et al. Deposits on retinal surface seen on OCT in ocular amyloidosis. Ophthalmol Retina. 2021;5:1005–8.
Benson MD. Liver transplantation and transthyretin amyloidosis. Muscle Nerve. 2013;47:157–62.
Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol. 2010;128:206–10.
Kakihara S, Hirano T, Imai A, Miyahara T, Murata T. Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis. Sci Rep. 2020;10:5574.
Thiagasorupan P, Barreau E, Gendron G, Frau E, Cauquil C, Adams D, et al. Specific postoperative complications of vitrectomy in hereditary transthyretin amyloidosis. Eur J Ophthalmol. 2022;32:1149–56.
Kawaji T, Inoue T, Hara R, Eiki D, Ando Y, Tanihara H. Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. PLoS ONE. 2014;9: e96324.
Kakihara S, Hirano T, Imai A, Miyahara T, Murata T. Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy. Jpn J Ophthalmol. 2020;64:533–8.
Marta A, Vieira R, Figueiredo A, Reis R, Sampaio I, Beirão JM, et al. Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis. Eye (Lond). 2022;36:111–8.
Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK. Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol. 2017;176:118–26.
Kasahara M, Shoji N. Effectiveness and limitations of minimally invasive glaucoma surgery targeting Schlemm’s canal. Jpn J Ophthalmol. 2021;65:6–22.
Tanito M, Ikeda Y, Fujihara E. Effectiveness and safety of combined cataract surgery and microhook ab interno trabeculotomy in Japanese eyes with glaucoma: report of an initial case series. Jpn J Ophthalmol. 2017;61:457–64.
Tanito M, Sano I, Ikeda Y, Fujihara E. Short-term results of microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery in Japanese eyes: initial case series. Acta Ophthalmol. 2017;95:e354–60.
Mori S, Tanito M, Shoji N, Yokoyama Y, Kameda T, Shoji T, et al. Noninferiority of microhook to trabectome: trabectome versus Ab Interno microhook trabeculotomy comparative study (tram trac study). Ophthalmol Glaucoma. 2022;5:452–61.
Sotani N, Kusuhara S, Matsumiya W, Okuda M, Mori S, Sotani R, et al. Outcomes of microhook Ab Interno trabeculotomy in consecutive 36 eyes with Uveitic glaucoma. J Clin Med. 2022;11:3768.
Omoto T, Fujishiro T, Asano-Shimizu K, Sugimoto K, Sakata R, Murata H, et al. Comparison of 12-month surgical outcomes of ab interno trabeculotomy with phacoemulsification between spatula-shaped and dual-blade microhooks. Jpn J Ophthalmol. 2021;65:402–8.
Barbosa NB, Grippo TM. Excisional goniotomy with Kahook Dual Blade in a patient with glaucoma secondary to Transthyretin Amyloidosis. Am J Ophthalmol Case Rep. 2020;19: 100750.
Scheie HG. Width and pigmentation of the angle of the anterior chamber; a system of grading by gonioscopy. AMA Arch Ophthalmol. 1957;58:510–2.
Shoji N, Kasahara M, Iijima A, Takahashi M, Tatsui S, Matsumura K, et al. Short-term evaluation of Trabectome surgery performed on Japanese patients with open-angle glaucoma. Jpn J Ophthalmol. 2016;60:156–65.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007–16.
Adams D, Gonzalez-Duarte A, O’Riordan WD, Yang CC, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379:11–21.
Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86:1036–43.
Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res. 2005;81:306–12.
Beirão NM, Matos ME, Meneres MJ, Beirão IM, Costa PP, Torres PA. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients. Amyloid. 2012;19:146–51.
Kakihara S, Hirano T, Kitahara J, Matsuda Y, Imai A, Miyahara T, et al. Ocular angiographic features in Japanese patients with val30met hereditary transthyretin amyloidosis. Retina. 2022;42:210–5.
Acknowledgements
The authors thank the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine for introducing patients with ATTRv to our department and the paramedical staff members in our team for helping to make this study possible. We would like to thank Editage (www.editage.com) for their writing support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
J. Kitahara, None; S. Kakihara, None; T. Hirano, None; Y. Takahashi, None; A. Imai, None; T. Miyahara, None; T. Murata, None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Author: Shinji Kakihara
About this article
Cite this article
Kitahara, J., Kakihara, S., Hirano, T. et al. Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosis. Jpn J Ophthalmol 67, 84–90 (2023). https://doi.org/10.1007/s10384-022-00966-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-022-00966-5